Ken Kodama

Up-regulation of Lewis enzyme (Fuc-TIII) and plasma-type ?1,3Fucosyltransferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis x antigen in non-small cell lung cancer

Akira Togayachi, Takashi Kudo, Yuzuru Ikehara et al. · International Journal of Cancer · 1999 · 33 citations

Levels of Complement Regulatory Molecules in Lung Cancer: Disappearance of the D17 Epitope of CD55 in Small‐cell Carcinoma

Takahiko Sakuma, Ken Kodama, T. Tural Kara et al. · Japanese Journal of Cancer Research · 1993 · 23 citations · Full text

Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs

Masahiki Higashiyama, Ken Kodama, Hideoki Yokouchi et al. · Journal of Surgical Oncology · 1998 · 22 citations

Homologous complement activation on drug-induced apoptotic cells from a human lung adenocarcinoma cell line

Tomoko Hara, Misako Matsumoto, Shotaro Tsuji et al. · Immunobiology · 1997 · 13 citations

Homologous Complement Activation, Complement System, Medicine +12

Dramatic response of postthymomectomy myasthenia gravis with multiple lung nodules to corticosteroids

Ken Kodama, Osamu Doi, Masahiko Higashiyama et al. · The Annals of Thoracic Surgery · 1997 · 11 citations

Multiple Lung Nodules, Dramatic Response, Postthymomectomy Myasthenia Gravis